Bio-Rad Laboratories Inc
Slēgts
SektorsVeselības aprūpe
278.8 2.85
Pārskats
Akcijas cenas izmaiņa
24h
Min
269.92
Max
283.35
Ienākumi | -731M -11M |
|---|---|
Pārdošana | -101M 592M |
P/E Sektora vidējais | 46.696 50.958 |
EPS | 1.89 |
Peļņas marža | -1.858 |
Darbinieki | 7,450 |
EBITDA | -751M -637M |
Rekomendācijas | Neitrāls |
|---|---|
Prognoze 12 mēnešiem | +11.44% upside |
Nākamie ieņēmumi | 2026. g. 30. jūl. |
|---|
Tirgus kapitalizācija | -235M 7.5B |
|---|---|
Iepriekšējā atvēršanas cena | 275.95 |
Iepriekšējā slēgšanas cena | 278.8 |
Ziņu noskaņojums
By Acuity
50%
50%
143 / 342 Rangs Healthcare
Bio-Rad Laboratories Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.